Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 79

1.

Screening program reduced melanoma mortality at the Lawrence Livermore National Laboratory, 1984 to 1996.

Schneider JS, Moore DH 2nd, Mendelsohn ML.

J Am Acad Dermatol. 2008 May;58(5):741-9. Epub 2008 Feb 20.

PMID:
18068264
2.

Cancer incidence rates among Lawrence Livermore National Laboratory (LLNL) employees: 1974-1997.

Whorton MD, Moore DN, Seward JP, Noonan KA, Mendelsohn ML.

Am J Ind Med. 2004 Jan;45(1):24-33.

PMID:
14691966
3.

Three somatic genetic biomarkers and covariates in radiation-exposed Russian cleanup workers of the chernobyl nuclear reactor 6-13 years after exposure.

Jones IM, Galick H, Kato P, Langlois RG, Mendelsohn ML, Murphy GA, Pleshanov P, Ramsey MJ, Thomas CB, Tucker JD, Tureva L, Vorobtsova I, Nelson DO.

Radiat Res. 2002 Oct;158(4):424-42.

PMID:
12236810
4.

Evaluation of three somatic genetic biomarkers as indicators of low dose radiation effects in clean-up workers of the Chernobyl nuclear reactor accident.

Jones IM, Tucker JD, Langlois RG, Mendelsohn ML, Pleshanov P, Nelson DO.

Radiat Prot Dosimetry. 2001;97(1):61-7.

PMID:
11763359
5.

A model for radiation-related cancer suggested by atomic bomb survivor data.

Pierce DA, Mendelsohn ML.

Radiat Res. 1999 Dec;152(6):642-54.

PMID:
10581535
6.

Twelfth Aspen Cancer Conference: mechanisms of toxicity and carcinogenesis.

Nesnow S, Harris CC, Trump BF, Mendelsohn ML, Dellarco V, Gilmer TM, Cavanee W, Tennant R.

Mol Carcinog. 1998 May;22(1):1-8. No abstract available.

PMID:
9609095
7.

Case-control study of malignant melanoma among employees of the Lawrence Livermore National Laboratory.

Moore DH 2nd, Patterson HW, Hatch F, Discher D, Schneider JS, Bennett D, Mendelsohn ML.

Am J Ind Med. 1997 Oct;32(4):377-91.

PMID:
9258392
8.

Somatic cell mutation as a radiation biodosimeter and predictor of cancer risk and aging.

Mendelsohn ML.

Jpn J Cancer Res. 1996 Sep;87(9):inside front cover. No abstract available.

PMID:
8878446
9.

The radiation effects research foundation of Hiroshima and Nagasaki. Past, present, and future.

Shigematsu I, Mendelsohn ML.

JAMA. 1995 Aug 2;274(5):425-6. No abstract available.

PMID:
7616640
10.

Antimutagenic effects in humans.

Mendelsohn ML.

Mutat Res. 1992 Jun;267(2):257-64. Review.

PMID:
1376428
11.

International Commission for Protection Against Environmental Mutagens and Carcinogens. A method for comparing and combining short-term genotoxicity test data: the basic system.

Lohman PH, Mendelsohn ML, Moore DH 2nd, Waters MD, Brusick DJ, Ashby J, Lohman WJ.

Mutat Res. 1992 Mar;266(1):7-25. No abstract available.

PMID:
1372964
14.

International Commission for Protection Against Environmental Mutagens and Carcinogens. A method for combining and comparing short-term genotoxicity test data: preface. A report from ICPEMC Committee 1.

Brusick DJ, Ashby J, de Serres FJ, Lohman PH, Matsushima T, Matter BE, Mendelsohn ML, Moore DH 2nd, Nesnow S, Waters MD.

Mutat Res. 1992 Mar;266(1):1-6. No abstract available.

PMID:
1372961
15.

An introduction to biological dosimetry.

Mendelsohn ML.

Prog Clin Biol Res. 1991;372:1-10. No abstract available.

PMID:
1956908
16.

New approaches for biological monitoring of radiation workers.

Mendelsohn ML.

Health Phys. 1990 Jul;59(1):23-8.

PMID:
2358356
17.

The assembly and analysis of short-term genotoxicity test data--an ICPEMC Committee 1 Working Paper.

Lohman PH, Mendelsohn ML, Moore DH 2nd, Waters MD, Brusick DJ.

Prog Clin Biol Res. 1990;340D:283-94. No abstract available.

PMID:
2371301
18.

Potential DNA methods for measuring the human heritable mutation rate.

Mendelsohn ML.

Genome. 1989;31(2):860-3. Review.

PMID:
2576654
19.

Can chemical carcinogenicity be predicted by short-term tests?

Mendelsohn ML.

Ann N Y Acad Sci. 1988;534:115-26. Review. No abstract available.

PMID:
3291705
20.

Biomarkers in the detection of human heritable and germinal mutagenesis.

Mendelsohn ML.

Environ Health Perspect. 1987 Oct;74:49-53.

21.
22.

Recommendations for screening for potential human germ cell mutagens: an ICPEMC Working Paper.

Bridges BA, Mendelsohn ML.

Prog Clin Biol Res. 1986;209B:51-65. No abstract available.

PMID:
3749105
23.

Short-term assays to predict carcinogenicity. Metabolic activation.

Venitt S, Bartsch H, Becking G, Fuchs RP, Hofnung M, Malaveille C, Matsushima T, Mendelsohn ML, Pegg AE, Roberfroid M, et al.

IARC Sci Publ. 1986;(83):439-55. Review. No abstract available.

PMID:
3305349
24.

Prospects for DNA methods to measure human heritable mutation rates.

Mendelsohn ML.

Prog Clin Biol Res. 1986;209B:337-44. No abstract available.

PMID:
3018774
25.

Prospects for cellular mutational assays in human populations.

Mendelsohn ML.

Basic Life Sci. 1985;33:415-27. No abstract available.

PMID:
4015593
26.

The DNA-based human karyotype.

Mayall BH, Carrano AV, Moore DH 2nd, Ashworth LK, Bennett DE, Mendelsohn ML.

Cytometry. 1984 Jul;5(4):376-85.

27.
28.

Roundtable discussion. Research priorities and perspectives: industry, universities, government.

Hollaender A, Ray VA, Mendelsohn ML, Lyons J, Valentine RC, Colton R, Rominger R.

Basic Life Sci. 1982;21:509-32. No abstract available.

PMID:
7150205
29.

Extrapolation of mutagenicity testing to the human.

Mendelsohn ML.

Basic Life Sci. 1982;21:113-6. No abstract available.

PMID:
7150188
30.

Optimization of radiotherapy.

Mendelsohn ML.

Int J Radiat Oncol Biol Phys. 1979 Oct;5(10):1923-4. No abstract available.

PMID:
528261
31.

Hydrodynamic orientation of sperm heads for flow cytometry.

Dean PN, Pinkel D, Mendelsohn ML.

Biophys J. 1978 Jul;23(1):7-13.

32.

Localization and therapeutic potential of tritiated tetracycline in rodent tumors.

Davis RC, Wood P, Mendelsohn ML.

Cancer Res. 1977 Dec;37(12):4539-45. No abstract available.

33.

Rapid cell cycle analysis by measurement of the radioactivity per cell in a narrow window in S phase (RCSi).

Gray JW, Carver JH, George YS, Mendelsohn ML.

Cell Tissue Kinet. 1977 Mar;10(2):97-109.

PMID:
322870
34.

Purification of the chromosomes of the Indian muntjac by flow sorting.

Carrano AV, Gray JW, Moore DH 2nd, Minkler JL, Mayall BH, van Dilla MA, Mendelsohn ML.

J Histochem Cytochem. 1976 Jan;24(1):348-54.

PMID:
1254929
35.

High-speed quantitative karyotyping by flow microfluorometry.

Gray JW, Carrano AV, Moore DH 2nd, Steinmetz LL, Minkler J, Mayall BH, Mendelsohn ML, Van Dilla MA.

Clin Chem. 1975 Aug;21(9):1258-62.

36.

Chromosome measurement and sorting by flow systems.

Gray JW, Carrano AV, Steinmetz LL, Van Dilla MA, Moore DH 2nd, Mayall BH, Mendelsohn ML.

Proc Natl Acad Sci U S A. 1975 Apr;72(4):1231-4.

37.

Proliferative capacity and DNA content of aging human diploid cells in culture: a cytophotometric and autoradiographic analysis.

Yanishevsky R, Mendelsohn ML, Mayall BH, Cristofalo VJ.

J Cell Physiol. 1974 Oct;84(2):165-70. No abstract available.

PMID:
4612051
38.

Computer-oriented analysis of human chromosomes. IV. Deoxyribonucleic acid-based centromeric index.

Mendelsohn ML, Bennett DE, Bogart E, Mayall BH.

J Histochem Cytochem. 1974 Jul;22(7):554-60. No abstract available.

PMID:
4136609
39.

DNA content and DNA-based centromeric index of the 24 human chromosomes.

Mendelsohn ML, Mayall BH, Bogart E, Moore DH 2nd, Perry BH.

Science. 1973 Mar 16;179(4078):1126-9.

PMID:
4120257
40.

Focus-assist device for a flying-spot microscope.

Kujoory MA, Mayall BH, Mendelsohn ML.

IEEE Trans Biomed Eng. 1973 Mar;20(2):126-32. No abstract available.

PMID:
4688303
41.

Computer-oriented analysis of human chromosomes. 3. Focus.

Mendelsohn ML, Mayall BH.

Comput Biol Med. 1972 Oct;2(2):137-50. No abstract available.

PMID:
4668644
42.

Optimal treatment levels in cancer therapy.

Moore DH, Mendelsohn ML.

Cancer. 1972 Jul;30(1):97-106. No abstract available.

PMID:
5040749
43.

The automatic analysis of FLM curves.

Takahashi M, Hogg JD Jr, Mendelsohn ML.

Cell Tissue Kinet. 1971 Nov;4(6):505-18. No abstract available.

PMID:
5169030
44.

The growth kinetics of solid tumors: summary report of meeting.

Mendelsohn ML, Shackney SE.

Cell Tissue Kinet. 1970 Oct;3(4):405-14. No abstract available.

PMID:
5523064
45.
46.

Cell cycle kinetics and mitotically linked chemotherapy.

Mendelsohn ML.

Cancer Res. 1969 Dec;29(12):2390-3. No abstract available.

47.

Generalized greyness profiles as applied to edge detection and the organization of chromosomal images.

Mendelsohn ML, Mayall BH, Perry BH.

Rev Latinoam Microbiol Parasitol (Mex). 1968 Apr-Jun;10(2):209. No abstract available.

PMID:
5264785
48.

Analysis of tumor growth curves.

Dethlefsen LA, Prewitt JM, Mendelsohn ML.

J Natl Cancer Inst. 1968 Feb;40(2):389-405. No abstract available.

PMID:
5638610
49.

Cell cloning experiments as models for radiotherapy: a critical appraisal.

Mendelsohn ML.

Natl Cancer Inst Monogr. 1967 Feb;24:157-67. No abstract available.

PMID:
6021075
50.

Kinetics of tumor cell proliferation.

Mendelsohn ML.

Bull N Y Acad Med. 1966 Jun;42(6):506-8. No abstract available.

Supplemental Content

Loading ...
Support Center